<H1>Chapter DOI: 10.1007/s10047-008-0415-6<br/>Cited-By Count: 11</H1><table border="1" width="30%"><tr><td>Total References</td><td>27</td></tr><tr><td>Springer references</td><td>0</td></tr><tr><td>Non Springer references</td><td>27</td></tr><tr><td>BibStructured Count</td><td width="10%">27</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>25</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>0</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>0</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>0</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Asimakopoulos G, Smith PLC, Patnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999;68:1107&#8211;1115</td><td><a href=http://dx.doi.org/10.1016/S0003-4975(99)00781-X>10.1016/S0003-4975(99)00781-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Paparella D, Yau TM, Young E. Cardiopulmonary bypass-induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232&#8211;244</td><td><a href=http://dx.doi.org/10.1016/S1010-7940(01)01099-5>10.1016/S1010-7940(01)01099-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Tonz M, Mihaljevic T, von Segesser LK, Fehr J, Schmid ER, Turina MI. Acute lung injury during cardiopulmonary bypass. Chest 1995;108:1551&#8211;1556</td><td><a href=http://dx.doi.org/10.1378/chest.108.6.1551>10.1378/chest.108.6.1551</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Heter EJ, Lee KS, Manspeizer HE, Mongero L, Spanier TB, Caliste X, Esrig B, Smith C. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. J Cardiothorac Vasc Anesth 2002;16:37&#8211;42</td><td><a href=http://dx.doi.org/10.1053/jcan.2002.29659>10.1053/jcan.2002.29659</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Pappalardo F, Valle PD, Crescenzi G, Corno C, Franco A, Torracca L, Alfieri O, Galli L, Zangrillo A, D&#8217;Angelo A. Phosphorycholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial. Ann Thorac Surg 2006;81:886&#8211;891</td><td><a href=http://dx.doi.org/10.1016/j.athoracsur.2005.09.006>10.1016/j.athoracsur.2005.09.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Rubens FD, Nathan H, Labow R, Williams KS, Wonzy D, Karsh J, Ruel M, Mesana T. Effects of methylprednisolone and biocompatible copolymer circuit on blood activation during cardiopulmonary bypass. Ann Thorac Surg 2005;79:655&#8211;665</td><td><a href=http://dx.doi.org/10.1016/j.athoracsur.2004.07.044>10.1016/j.athoracsur.2004.07.044</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Wimmer-Greinecker G, Matheis G, Matens S, Oremek G, Adbel-Rahman U, Moritz A. Synthetic protein-treated versus heparincoated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences. Eur J Cardiothorac Surg 1999; 16:211&#8211;217</td><td><a href=http://dx.doi.org/10.1016/S1010-7940(99)00143-8>10.1016/S1010-7940(99)00143-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Boning A, Scheewe J, Ivers T, Friedrich C, Stieh J, Freitag S, Cremer JT. Phosphorylcholine or heparin coating for pediatric extracorporeal circulation causes similar biologic effects in neonates and infants. J Thorac Cardiovasc Surg 2004;127:1458&#8211;1465</td><td><a href=http://dx.doi.org/10.1016/j.jtcvs.2003.08.051>10.1016/j.jtcvs.2003.08.051</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Tanaka M, Motomura T, Kawada M, Anzai T, Kasori Y, Shiroya T, Shimura K, Onishi M, Mochizuki A. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA)-relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 2000;21:1471&#8211;1481</td><td><a href=http://dx.doi.org/10.1016/S0142-9612(00)00031-4>10.1016/S0142-9612(00)00031-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Baykut D, Wehrle BJ, Weichelt K, Schwartz P, Zerkowski HR. New surface biopolymers for oxygenators: an in vitro hemocompatibility test of poly(2-methoxyethylacrylate). Eur J Med Res 2001;6:297&#8211;305</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Saito N, Motoyama S, Sawamoto J. Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass. Artif Organs 2000;24:547&#8211;554</td><td><a href=http://dx.doi.org/10.1046/j.1525-1594.2000.06520.x>10.1046/j.1525-1594.2000.06520.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Suhara H, Sawa Y, Nishimura M, Oshiyama H, Yokoyama K, Saito N, Matsuda H. Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg 2001;71:1603&#8211;1608</td><td><a href=http://dx.doi.org/10.1016/S0003-4975(01)02466-3>10.1016/S0003-4975(01)02466-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Ninomiya M, Miyaji K, Takamoto S. Influence of PMEA-coated bypass circuits on perioperative inflammatory response. Ann Thorac Surg 2003;75:913&#8211;917, discussion 7-8</td><td><a href=http://dx.doi.org/10.1016/S0003-4975(02)04407-7>10.1016/S0003-4975(02)04407-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Gunaydin S, Farsak B, Kocakulak M, Sari T, Yorgancioglu C, Zorlutuna Y. Clinical performance and biocompatibility of poly (2-methoxyethylacrylate)-coated extracorporeal circuits. Ann Thorac Surg 2002;74:819&#8211;824</td><td><a href=http://dx.doi.org/10.1016/S0003-4975(02)03796-7>10.1016/S0003-4975(02)03796-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Ikuta T, Fujii H, Shibata T, Hattori K, Hirai H, Kumano H, Suehiro S. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg 2004;77:1678&#8211;1683</td><td><a href=http://dx.doi.org/10.1016/j.athoracsur.2003.10.060>10.1016/j.athoracsur.2003.10.060</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Eisses MJ, Geiduschek JM, Jonmarker C, Cohen GA, Chandler WL. Effect of polymer coating (poly-2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 2007;21:28&#8211;34</td><td><a href=http://dx.doi.org/10.1053/j.jvca.2006.03.023>10.1053/j.jvca.2006.03.023</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Kirshbom PM, Miller BE, Spitzer K, Easley KA, Spainhour CE, Kogon BE, Kanter KR. Failure of surface-modified bypass circuits to improve platelet function during pediatric cardiac surgery J Thorac Cardiovasc Surg 2006;132:675&#8211;680</td><td><a href=http://dx.doi.org/10.1016/j.jtcvs.2006.05.035>10.1016/j.jtcvs.2006.05.035</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Yoshimura K, Nakagawa S, Koyama S, Kobayashi T, Homma T. Roles of neutrophil elastase and superoxide anion in leukotriene B4-induced lung injury in rabbit. J Appl Physiol 1994;76:91&#8211;96</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Ilton MK, Langton PE, Taylor ML, Misso NLA, Newman M, Thompson PJ, Hung J. Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999;118:930&#8211;937</td><td><a href=http://dx.doi.org/10.1016/S0022-5223(99)70064-4>10.1016/S0022-5223(99)70064-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999;43: 860&#8211;878</td><td><a href=http://dx.doi.org/10.1016/S0008-6363(99)00187-X>10.1016/S0008-6363(99)00187-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Grossi EA, Kallenbach K, Chau S, Derivaux CC, Aguinaga MG, Steinberg BM, Kim D, Iyer S, Tayyarah M, Artman M, Galloway AC, Colvin SB. Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study. Ann Thorac Surg 2000;70:191&#8211;196</td><td><a href=http://dx.doi.org/10.1016/S0003-4975(00)01319-9>10.1016/S0003-4975(00)01319-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Olsson C, Siegban A, Halden E, Nilsson B, Venge P, Thelin S. No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuit. Ann Thorac Surg 2000;69:743&#8211;749</td><td><a href=http://dx.doi.org/10.1016/S0003-4975(99)01502-7>10.1016/S0003-4975(99)01502-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Gorman RC, Ziats NP, Rao AK, Gikakis N, Sun L, Khan MMH, Stenach N, Sapatnekar S, Chouhan V, Gorman III JH, Niewiarowski S, Colman RW, Anderson JM, Edmunds Jr LH. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 111:1&#8211;12</td><td><a href=http://dx.doi.org/10.1016/S0022-5223(96)70395-1>10.1016/S0022-5223(96)70395-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Wakayama F, Fukuda I, Suzuki Y, Kondo N. Neutrophil elastase inhibitor, Sivelestat, attenuates acute lung injury after cardiopulmonary bypass in the rabbit endotoxemia model. Ann Thorac Surg 2007;83:153&#8211;160</td><td><a href=http://dx.doi.org/10.1016/j.athoracsur.2006.08.023>10.1016/j.athoracsur.2006.08.023</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Edmunds LH Jr, Colman RC. Thrombin during cardiopulmonary bypass. Ann Thorac Surg 2006;82:2315&#8211;2322</td><td><a href=http://dx.doi.org/10.1016/j.athoracsur.2006.06.072>10.1016/j.athoracsur.2006.06.072</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI, Shin YT, Curits WE, Verrier ED. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742&#8211;755</td><td><a href=http://dx.doi.org/10.1067/mtc.2002.120347>10.1067/mtc.2002.120347</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>De Somer F, Van Belleghem Y, Caes F, Francois K, Overbeke HV, Arnout J, Taeymans Y, Nooten GV. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002;123:951&#8211;958</td><td><a href=http://dx.doi.org/10.1067/mtc.2002.120334>10.1067/mtc.2002.120334</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>